USPTO serial 98726753
ENCHANT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 28, 2026
- Examiner
- MINAYA, NYASIA ALYSSA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ENCHANT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alyssa M. Worsham
Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | technical scientific consultation and product development for others in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; development of materials, software, artificial intelligence, chemicals, and pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; research and development of treatment protocols for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in science, chemistry, biology, physics, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, technology, chemical engineering, computer science, medicine and healthcare, and design and optimization of molecules, materials, catalysts, chemicals, and drugs; chemistry consultation services in the nature of drugs, materials, chemicals, and molecular discovery services; product development services; chemical research and chemistry consultation in the field of drug, materials, chemicals, and molecular development; providing online non-downloadable software for simulations for drug, materials, chemicals, and molecular discovery; software as a service (SAAS) services featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; platform as a service (PAAS) featuring computer software platforms for use in optimizing drug, materials, chemicals, and molecular discovery; software as a services (SAAS) services in the nature of hosting software for cloud-based computing for the development of new molecules and designing and discovering molecules, drugs, and other molecular products; research and development of pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform; drug discovery services; design and development of computer software; providing online non-downloadable computer software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; platform as a service (PAAS) featuring computer software platforms using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; platform as a service (PAAS) featuring artificial intelligence computer software platforms for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; software as a service (SAAS) featuring software using artificial intelligence and machine learning for predicting properties of molecules and discovering molecules in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, biochemistry, computational chemistry, artificial intelligence, technology, computer science, chemical engineering, medicine, and healthcare; software as a service (SAAS) featuring artificial intelligence software for use in the research and development of materials, software, artificial intelligence, chemicals, catalysts, and pharmaceutical products including pharmaceutical preparations and medicines; providing online non-downloadable computer software for scientific analysis; providing online non-downloadable software, namely, software for use in designing and developing artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality in the fields of science, chemistry, physics, biology, physical chemistry, chemical physics, molecular engineering, materials science, catalysis, computational chemistry, technology, computer science, chemical engineering, medicine, and healthcare; providing online non-downloadable computer software for use in determining properties or physical characteristics of organic compounds, inorganic compounds, organic materials, inorganic materials; scientific and technological services, namely, scientific and technical consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology and scientific research and new product design services; Industrial research services in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; Industrial analysis in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; scientific and technological services, namely, computer aided scientific analysis in the field of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, science, chemistry, physics, and biology; computer modeling services; scientific research into organic compounds; scientific services, namely, analysis of organic compounds, inorganic compounds, organic materials, inorganic materials; crystal analysis services for scientific research purposes; research in the field of computer natural language processing; medical and scientific research in the field of machine learning and models to evaluate drug compounds pharmacological properties; medical and scientific research services in the field of machine learning models to evaluate bioactivity and pharmacological properties of drug compounds; medical and scientific research services in the field of machine learning models to generate and evaluate drug compounds for specific pharmacological and bioactivity effects and results; medical and scientific research services in the field of machine learning models to evaluate drug compounds and their efficacy and side effects for purposes of clinical trials; medical and scientific research services in the field of machine learning models to generate and evaluate treatment protocols for purposes of clinical trials | ACTIVE | Sep 23, 2024 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 28, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 28, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 4, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jul 4, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 25, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| May 25, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 23, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 22, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jan 22, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jan 22, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 22, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 22, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 22, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 27, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 27, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 21, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 29, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 28, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 30, 2024 | NWAP | NEW APPLICATION ENTERED | — |